Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (P ...
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.087
https://www.valueinhealthjournal.com/article/S1098-3015(17)30421-7/fulltext
Title :
Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (P ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30421-7&doi=10.1016/j.jval.2017.08.087
First page :
A412
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
69